UP
koKRtier 1 1분
[신라젠] 투자판단관련주요경영사항(임상시험계획승인신청) (덱시부프로펜주(WS2405)의 제 1상 임상시험 계획 승인 신청)
No RSS summary is available. Open the original link to read more.
Company
SillaJen, Inc.
Showing 5 RSS articles and DART filings mapped to this company, sorted by time.
No RSS summary is available. Open the original link to read more.
No RSS summary is available. Open the original link to read more.
No RSS summary is available. Open the original link to read more.
No RSS summary is available. Open the original link to read more.